Thrainsdottir I, Malmberg K, Olsson A, Gutniak M, Ryden L: Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure
Initially developed for type 2 diabetes, these agents are now widely used to achieve significant weight loss in individuals with obesity or overweight with comorbidities
How To Know My Macros Mar 31, 2026 Know your macros
SMD 0.114)
(NYSE: MED) is excited to introduce a new product line under the #OPTAVIA Ascend brand, designed to support individuals on GLP-1 medications as part of a structured nutrition support plan
Do not freeze injectable medicine, and ask before using it if the carton, device, solution, or temperature exposure seems concerning